학술논문

Essential role of growth hormone in ischemia-induced retinal neovascularization
Document Type
Academic Journal
Source
Science. June 13, 1997, Vol. 276 Issue 5319, p1706, 4 p.
Subject
Blindness -- Prevention
Somatotropin -- Physiological aspects
Insulin-like growth factor 1 -- Physiological aspects
Retinal diseases -- Physiological aspects -- Prevention
Retina -- Blood-vessels
Science and technology
Prevention
Physiological aspects
Language
English
ISSN
0036-8075
Abstract
Retinal neovascularization is the major cause of untreatable blindness. The role of growth hormone (GH) in ischemia-associated retinal neovascularization was studied in transgenic mice expressing a GH antagonist gene and in normal mice given an inhibitor of GH secretion (MK678). Retinal neovascularization was inhibited in these mice in inverse proportion to serum levels of GH and a downstream effector, insulin-like growth factor-I (IGF-I). Inhibition was reversed with exogenous IGF-I administration. GH inhibition did not diminish hypoxia-stimulated retinal vascular endothelial growth factor (VEGF) or VEGF receptor expression. These data suggest that systemic inhibition of GH or IGF-I, or both, may have therapeutic potential in preventing some forms of retinopathy.
Neovascularization, the final common pathway in diabetic retinopathy, retinopathy of prematurity, and age-related macular degeneration can cause vision loss. Surgical ablative treatments are incompletely effective and destroy retinal tissue, causing [...]